Chugai Pharmaceutical Lifts Nine-Month Profit as Revenue Grows
Chugai Pharmaceutical reported nine-month earnings of JPY375.3 billion, up from JPY305.6 billion a year earlier, with revenue up 17.2%, per TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Japan's Chugai Pharmaceutical posted nine-month earnings of JPY375.302 billion, or JPY228.07 per share, compared with JPY305.602 billion, or JPY185.70 per share, a year earlier.
Revenue for the period rose 17.2% to JPY1.068 trillion from JPY911.640 billion. The company's full-year 2026 revenue guidance stands at JPY1.345 trillion, and it expects core earnings per share of JPY295.00. The figures were reported by TradingView, citing RTTNews and dpa-AFX.
why it matters
Profit growing faster than revenue points to solid operating momentum. For investors this is a single-company report, so its effect on the broader market is limited, though it matters for interest in Japan's pharma sector.
tags
instruments
sources
- Chugai Pharmaceutical Co., Ltd Bottom Line Climbs In Nine Months — TradingView, 27 October 2026 at 08:53 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗